Short pages

Jump to navigation Jump to search

Showing below up to 250 results in range #251 to #500.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. (hist) ‎Gamma ray ‎[229 bytes]
  2. (hist) ‎Scintigraphy ‎[233 bytes]
  3. (hist) ‎Right to know ‎[234 bytes]
  4. (hist) ‎Reasonableness ‎[235 bytes]
  5. (hist) ‎Excretion rate (instantaneous) ‎[235 bytes]
  6. (hist) ‎Individual decontamination ‎[235 bytes]
  7. (hist) ‎Inhalability ‎[235 bytes]
  8. (hist) ‎Procedural values ‎[236 bytes]
  9. (hist) ‎Exposure situation ‎[237 bytes]
  10. (hist) ‎Recovery ‎[237 bytes]
  11. (hist) ‎Differentiation ‎[237 bytes]
  12. (hist) ‎Growth hormone (somatotropin) ‎[237 bytes]
  13. (hist) ‎Genomic integrity ‎[238 bytes]
  14. (hist) ‎Dichotomous ‎[239 bytes]
  15. (hist) ‎Autonomy ‎[240 bytes]
  16. (hist) ‎Isotropic geometry ‎[240 bytes]
  17. (hist) ‎Rb ‎[240 bytes]
  18. (hist) ‎Stenosis ‎[241 bytes]
  19. (hist) ‎Storage ‎[241 bytes]
  20. (hist) ‎Cobblestone area forming cell assay ‎[241 bytes]
  21. (hist) ‎Half-life, physical ‎[242 bytes]
  22. (hist) ‎Radiation modifier ‎[243 bytes]
  23. (hist) ‎Hyperbaric oxygen ‎[243 bytes]
  24. (hist) ‎Gray ‎[244 bytes]
  25. (hist) ‎Dose modifying factor ‎[245 bytes]
  26. (hist) ‎Test ‎[246 bytes]
  27. (hist) ‎Edema ‎[246 bytes]
  28. (hist) ‎Mitigation ‎[246 bytes]
  29. (hist) ‎Hypoplasia ‎[249 bytes]
  30. (hist) ‎Cytokines ‎[249 bytes]
  31. (hist) ‎Waste management ‎[249 bytes]
  32. (hist) ‎Cumulative dose ‎[250 bytes]
  33. (hist) ‎Effect Dose 50 ‎[252 bytes]
  34. (hist) ‎Exposure pathway ‎[252 bytes]
  35. (hist) ‎Pilomatricoma ‎[252 bytes]
  36. (hist) ‎Coster-Kronig transition ‎[253 bytes]
  37. (hist) ‎Baseline disease rates ‎[253 bytes]
  38. (hist) ‎Designated area ‎[254 bytes]
  39. (hist) ‎Annual intake ‎[254 bytes]
  40. (hist) ‎Brachytherapy ‎[255 bytes]
  41. (hist) ‎Protection strategy ‎[256 bytes]
  42. (hist) ‎Remediation ‎[256 bytes]
  43. (hist) ‎Life Span Study ‎[256 bytes]
  44. (hist) ‎Representative person ‎[257 bytes]
  45. (hist) ‎Graded approach ‎[259 bytes]
  46. (hist) ‎Elemental dose ‎[259 bytes]
  47. (hist) ‎Nominal risk coefficient ‎[259 bytes]
  48. (hist) ‎DNA damage signalling ‎[260 bytes]
  49. (hist) ‎Thermodynamic diameter ‎[260 bytes]
  50. (hist) ‎Xerostomia ‎[261 bytes]
  51. (hist) ‎Bronchiolar region ‎[261 bytes]
  52. (hist) ‎Wisdom ‎[262 bytes]
  53. (hist) ‎Disposal ‎[265 bytes]
  54. (hist) ‎Necrosis ‎[266 bytes]
  55. (hist) ‎Principle of application of dose limits ‎[267 bytes]
  56. (hist) ‎Potentially lethal damage repair ‎[267 bytes]
  57. (hist) ‎Hormones ‎[268 bytes]
  58. (hist) ‎Radiation source ‎[269 bytes]
  59. (hist) ‎Exogenous excretion ‎[269 bytes]
  60. (hist) ‎Prevailing circumstances ‎[270 bytes]
  61. (hist) ‎Accelerated fractionation ‎[271 bytes]
  62. (hist) ‎Heliosphere ‎[271 bytes]
  63. (hist) ‎Uptake ‎[271 bytes]
  64. (hist) ‎Decay constant ‎[272 bytes]
  65. (hist) ‎Emergency exposure situation ‎[273 bytes]
  66. (hist) ‎Adventitious ‎[273 bytes]
  67. (hist) ‎Alimentary tract ‎[273 bytes]
  68. (hist) ‎Clonogenic cells ‎[273 bytes]
  69. (hist) ‎Occupational exposure ‎[274 bytes]
  70. (hist) ‎Other (systemic) tissues ‎[274 bytes]
  71. (hist) ‎Intermediate level waste ‎[275 bytes]
  72. (hist) ‎Spontaneous fission ‎[276 bytes]
  73. (hist) ‎Connective tissue ‎[276 bytes]
  74. (hist) ‎Representative organism (non-human biota) ‎[277 bytes]
  75. (hist) ‎Time factor ‎[277 bytes]
  76. (hist) ‎Action Level ‎[278 bytes]
  77. (hist) ‎Access control ‎[278 bytes]
  78. (hist) ‎Emergency procedures ‎[280 bytes]
  79. (hist) ‎Multistage tumorigenesis ‎[282 bytes]
  80. (hist) ‎Slow repair ‎[282 bytes]
  81. (hist) ‎Unsealed source ‎[283 bytes]
  82. (hist) ‎Basal cell ‎[283 bytes]
  83. (hist) ‎Solar cycle ‎[284 bytes]
  84. (hist) ‎Oncogene ‎[284 bytes]
  85. (hist) ‎Safety case ‎[285 bytes]
  86. (hist) ‎Upper reference levels ‎[286 bytes]
  87. (hist) ‎Human Alimentary Tract Model ‎[286 bytes]
  88. (hist) ‎Radiation worker ‎[288 bytes]
  89. (hist) ‎Inclusiveness ‎[289 bytes]
  90. (hist) ‎Fractionation sensitivity ‎[289 bytes]
  91. (hist) ‎Health Surveillance ‎[290 bytes]
  92. (hist) ‎Hazard ‎[291 bytes]
  93. (hist) ‎AML/eto ‎[291 bytes]
  94. (hist) ‎Gastroschisis ‎[291 bytes]
  95. (hist) ‎Practical radiological protection culture ‎[292 bytes]
  96. (hist) ‎Alveolar-interstitial region ‎[292 bytes]
  97. (hist) ‎South Atlantic anomaly ‎[292 bytes]
  98. (hist) ‎Transparency ‎[294 bytes]
  99. (hist) ‎Tachycardia ‎[295 bytes]
  100. (hist) ‎Decommissioning ‎[295 bytes]
  101. (hist) ‎Unattached fraction ‎[295 bytes]
  102. (hist) ‎Exponential survival curve ‎[296 bytes]
  103. (hist) ‎Alimentary tract transfer factor ‎[296 bytes]
  104. (hist) ‎Activation ‎[296 bytes]
  105. (hist) ‎Expanded and aligned radiation field ‎[296 bytes]
  106. (hist) ‎Cardiomyopathy ‎[298 bytes]
  107. (hist) ‎Teratocarcinoma ‎[302 bytes]
  108. (hist) ‎Auger transition ‎[303 bytes]
  109. (hist) ‎Hierarchical tissues ‎[303 bytes]
  110. (hist) ‎Protective action guide ‎[303 bytes]
  111. (hist) ‎Diastasis ‎[304 bytes]
  112. (hist) ‎Dose-threshold ‎[304 bytes]
  113. (hist) ‎Organ at risk ‎[304 bytes]
  114. (hist) ‎Inner bremsstrahlung ‎[305 bytes]
  115. (hist) ‎Transfer of risk ‎[305 bytes]
  116. (hist) ‎Spread-out Bragg peak ‎[305 bytes]
  117. (hist) ‎Human Respiratory Tract Model ‎[305 bytes]
  118. (hist) ‎Count median diameter ‎[305 bytes]
  119. (hist) ‎Safety ‎[306 bytes]
  120. (hist) ‎Distribution coefficient ‎[306 bytes]
  121. (hist) ‎Clearance level ‎[307 bytes]
  122. (hist) ‎Alpha decay ‎[309 bytes]
  123. (hist) ‎Forbiddenness ‎[309 bytes]
  124. (hist) ‎Derived reference level ‎[311 bytes]
  125. (hist) ‎Ethics ‎[312 bytes]
  126. (hist) ‎Electron-capture decay ‎[312 bytes]
  127. (hist) ‎Gastrointestinal syndrome ‎[312 bytes]
  128. (hist) ‎Slice ‎[312 bytes]
  129. (hist) ‎Equity ‎[315 bytes]
  130. (hist) ‎Incident ‎[316 bytes]
  131. (hist) ‎Sealed source ‎[318 bytes]
  132. (hist) ‎Automatic exposure control ‎[318 bytes]
  133. (hist) ‎Particle transport ‎[318 bytes]
  134. (hist) ‎Active (red) bone marrow ‎[319 bytes]
  135. (hist) ‎Cardiac valve diseases ‎[319 bytes]
  136. (hist) ‎Solar particle event ‎[319 bytes]
  137. (hist) ‎Radiosensitivity, cellular ‎[319 bytes]
  138. (hist) ‎Beta-minus decay ‎[321 bytes]
  139. (hist) ‎Targeted effects ‎[321 bytes]
  140. (hist) ‎GATA binding protein 2 ‎[321 bytes]
  141. (hist) ‎Exposure, external or internal ‎[322 bytes]
  142. (hist) ‎Deontological Ethics ‎[323 bytes]
  143. (hist) ‎Solar cosmic radiation ‎[323 bytes]
  144. (hist) ‎Additive risk projection model ‎[323 bytes]
  145. (hist) ‎Referrer ‎[323 bytes]
  146. (hist) ‎Interphase death ‎[324 bytes]
  147. (hist) ‎Myocardial stress test ‎[325 bytes]
  148. (hist) ‎Beta-plus decay ‎[326 bytes]
  149. (hist) ‎Platelet-derived growth factor ‎[326 bytes]
  150. (hist) ‎Protective action ‎[327 bytes]
  151. (hist) ‎Internal conversion electron ‎[327 bytes]
  152. (hist) ‎Multiplicative risk projection model ‎[328 bytes]
  153. (hist) ‎Cost-benefit analysis ‎[329 bytes]
  154. (hist) ‎Source-related ‎[329 bytes]
  155. (hist) ‎Somatic effect ‎[329 bytes]
  156. (hist) ‎Redox ‎[329 bytes]
  157. (hist) ‎Nominal value ‎[330 bytes]
  158. (hist) ‎DRL process ‎[330 bytes]
  159. (hist) ‎Dose criteria ‎[331 bytes]
  160. (hist) ‎Linear-non-threshold model ‎[331 bytes]
  161. (hist) ‎Emergency preparedness ‎[331 bytes]
  162. (hist) ‎Severe deterministic injury ‎[331 bytes]
  163. (hist) ‎Population risk ‎[331 bytes]
  164. (hist) ‎Best available techniques ‎[331 bytes]
  165. (hist) ‎Ras ‎[331 bytes]
  166. (hist) ‎Shielding ‎[331 bytes]
  167. (hist) ‎Valvular heart disease ‎[332 bytes]
  168. (hist) ‎Equilibrium equivalent concentration ‎[332 bytes]
  169. (hist) ‎Retrievability ‎[334 bytes]
  170. (hist) ‎Residual dose ‎[335 bytes]
  171. (hist) ‎Annual dose ‎[336 bytes]
  172. (hist) ‎Worker ‎[336 bytes]
  173. (hist) ‎Naturally occurring radioactive material ‎[337 bytes]
  174. (hist) ‎Myocardial perfusion ‎[337 bytes]
  175. (hist) ‎Reference parameter value ‎[337 bytes]
  176. (hist) ‎Rigidity threshold ‎[340 bytes]
  177. (hist) ‎National radon survey ‎[340 bytes]
  178. (hist) ‎Reversibility ‎[341 bytes]
  179. (hist) ‎Rigidity ‎[343 bytes]
  180. (hist) ‎Transfer compartment ‎[343 bytes]
  181. (hist) ‎Radiation risk ‎[343 bytes]
  182. (hist) ‎Clonogenic survival ‎[344 bytes]
  183. (hist) ‎Co-expertise ‎[345 bytes]
  184. (hist) ‎Neurological syndrome ‎[345 bytes]
  185. (hist) ‎Disposal facility ‎[346 bytes]
  186. (hist) ‎Graft vs host disease ‎[346 bytes]
  187. (hist) ‎Dose rate effectiveness factor ‎[347 bytes]
  188. (hist) ‎Normal tissue complication probability ‎[347 bytes]
  189. (hist) ‎Derived limit ‎[347 bytes]
  190. (hist) ‎Regional diagnostic reference levels ‎[349 bytes]
  191. (hist) ‎Electrophysiology ‎[350 bytes]
  192. (hist) ‎Specific absorbed fraction ‎[350 bytes]
  193. (hist) ‎Consequential late effects ‎[352 bytes]
  194. (hist) ‎Surface contamination ‎[353 bytes]
  195. (hist) ‎Radiological protection principles ‎[354 bytes]
  196. (hist) ‎Gastrulation ‎[354 bytes]
  197. (hist) ‎Relative survival ‎[354 bytes]
  198. (hist) ‎Deposition ‎[354 bytes]
  199. (hist) ‎Fluoroscopically guided interventions ‎[355 bytes]
  200. (hist) ‎Sublethal damage repair ‎[356 bytes]
  201. (hist) ‎Allometry ‎[356 bytes]
  202. (hist) ‎Reference biokinetic model ‎[357 bytes]
  203. (hist) ‎Waste disposal ‎[357 bytes]
  204. (hist) ‎Quality control testing ‎[357 bytes]
  205. (hist) ‎Habitual mouth breather ‎[358 bytes]
  206. (hist) ‎Detriment-adjusted risk ‎[358 bytes]
  207. (hist) ‎Active detection system ‎[358 bytes]
  208. (hist) ‎Licensee ‎[358 bytes]
  209. (hist) ‎Biological half-life ‎[358 bytes]
  210. (hist) ‎Compartment (environmental) ‎[360 bytes]
  211. (hist) ‎Field-size effect (Volume effect) ‎[361 bytes]
  212. (hist) ‎Activity ‎[362 bytes]
  213. (hist) ‎Angiogenesis ‎[363 bytes]
  214. (hist) ‎In vivo radiobioassay ‎[363 bytes]
  215. (hist) ‎Radon-prone area ‎[363 bytes]
  216. (hist) ‎Isomers ‎[364 bytes]
  217. (hist) ‎Source region ‎[364 bytes]
  218. (hist) ‎Bradycardia ‎[365 bytes]
  219. (hist) ‎Multistage carcinogenesis model ‎[365 bytes]
  220. (hist) ‎Source-related assessment ‎[365 bytes]
  221. (hist) ‎Transgenerational effect ‎[366 bytes]
  222. (hist) ‎Dose conversion convention ‎[367 bytes]
  223. (hist) ‎Planned exposure situation ‎[369 bytes]
  224. (hist) ‎Pericarditis ‎[369 bytes]
  225. (hist) ‎Hereditary effect ‎[370 bytes]
  226. (hist) ‎Commissioning ‎[370 bytes]
  227. (hist) ‎DS86 ‎[370 bytes]
  228. (hist) ‎Radiation safety officer ‎[371 bytes]
  229. (hist) ‎Clonogenic surviving fraction ‎[371 bytes]
  230. (hist) ‎Early normal tissue responses ‎[372 bytes]
  231. (hist) ‎Non-sphericity parameter ‎[373 bytes]
  232. (hist) ‎Immune system ‎[373 bytes]
  233. (hist) ‎Constancy test ‎[375 bytes]
  234. (hist) ‎Radiosensitiser ‎[375 bytes]
  235. (hist) ‎Trapped particles ‎[376 bytes]
  236. (hist) ‎Relative life lost ‎[376 bytes]
  237. (hist) ‎Lymphatic system ‎[377 bytes]
  238. (hist) ‎Senescence ‎[378 bytes]
  239. (hist) ‎Radiological controlled area ‎[379 bytes]
  240. (hist) ‎Erythropoietin ‎[381 bytes]
  241. (hist) ‎Dose-response function ‎[381 bytes]
  242. (hist) ‎Cardioverter-defibrillator ‎[383 bytes]
  243. (hist) ‎Phantom ‎[384 bytes]
  244. (hist) ‎Individual monitoring ‎[385 bytes]
  245. (hist) ‎Habitual nose breather ‎[386 bytes]
  246. (hist) ‎Acceptance test ‎[390 bytes]
  247. (hist) ‎Low dose rate ‎[390 bytes]
  248. (hist) ‎Broad beam therapy irradiation technique ‎[390 bytes]
  249. (hist) ‎Orphan source ‎[391 bytes]
  250. (hist) ‎Radioresponsiveness ‎[392 bytes]

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://icrpaedia.org/Special:ShortPages"